Full Text View
Tabular View
No Study Results Posted
Related Studies
Bladder Cancer Case Control Study of Arsenic in Water
This study has been completed.
First Received: February 22, 2001   Last Updated: March 22, 2006   History of Changes
Sponsored by: National Institute of Environmental Health Sciences (NIEHS)
Information provided by: National Institute of Environmental Health Sciences (NIEHS)
ClinicalTrials.gov Identifier: NCT00011518
  Purpose

This study is examining the relationship between ingested arsenic and bladder cancer in two areas of California where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels.


Condition
Bladder Cancer

Genetics Home Reference related topics: bladder cancer
MedlinePlus related topics: Arsenic Bladder Cancer Cancer Drinking Water
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Case Control, Retrospective Study

Further study details as provided by National Institute of Environmental Health Sciences (NIEHS):

Estimated Enrollment: 600
Study Start Date: October 1997
Estimated Study Completion Date: July 2001
Detailed Description:

Water supplies in many parts of the world contain naturally occurring arsenic. Previous studies have shown that arsenic at high doses can cause cancer of the bladder. The risk at lower doses is unknown. This study is examining the relationship between ingested arsenic and bladder cancer in central Nevada and Kings County, California, two areas where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels. Approximately 200 people with bladder cancer and 400 people without bladder cancer will be included. Subjects are interviewed by telephone about past residences, occupations, diet, drinking water consumption, and other lifestyle factors. Arsenic measurements in well water have been collected from the appropriate state agencies and are being matched with residences and drinking water consumption rates to estimate lifetime arsenic exposures for each subject. People with bladder cancer will then be compared to those without to see if people with cancer were more likely to have lived in areas with arsenic in their drinking water.

  Eligibility

Ages Eligible for Study:   20 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Cases must meet the following criteria:

  • Diagnosed with primary bladder cancer from January 1, 1997 until December 31, 2000.
  • Live in the following counties at the time of diagnosis: Churchill, Lyon, Mineral, Storey, Douglas, Carson City, Nevada, and Kings County, California
  • Ages 20-85 at the time of diagnosis.

Controls will be matched to cases based on gender and five year age groups.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00011518

Locations
United States, California
Allan Smith Research Office
Berkeley, California, United States, 94720
Sponsors and Collaborators
  More Information

No publications provided

Study ID Numbers: 7459-CP-001
Study First Received: February 22, 2001
Last Updated: March 22, 2006
ClinicalTrials.gov Identifier: NCT00011518     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institute of Environmental Health Sciences (NIEHS):
Arsenic
Bladder Cancer
Drinking Water

Study placed in the following topic categories:
Urinary Tract Neoplasm
Cystocele
Urologic Diseases
Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urogenital Neoplasms
Bladder Neoplasm
Urologic Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Urologic Diseases
Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urogenital Neoplasms
Urologic Neoplasms

ClinicalTrials.gov processed this record on May 06, 2009